Rigel Pharmaceutical Inc. buy HC Wainwright
Start price
22.02.24
/
50%
€1.24
Target price
22.02.25
€13.86
Performance (%)
-10.04%
Price
03.05.24
€1.11
Summary
This prediction is currently active. The prediction for Rigel Pharmaceutical Inc. disappoints with a performance of -10.04%. This prediction currently runs until 22.02.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rigel Pharmaceutical Inc. | 8.602% | 8.602% |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by HC_Wainwright for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for RIGL provided by MarketBeat
Stopped prediction by HC_Wainwright for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.41
06.03.24
06.03.24
€13.77
06.03.25
06.03.25
-20.98%
03.05.24
03.05.24
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.37
04.01.24
04.01.24
€13.69
04.01.25
04.01.25
-18.67%
03.05.24
03.05.24
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.15
08.12.23
08.12.23
€13.91
08.12.24
08.12.24
-3.39%
03.05.24
03.05.24
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.17
02.08.23
02.08.23
€13.71
02.08.24
02.08.24
-5.04%
03.05.24
03.05.24